Search Results

Job Creations

Massachusetts Tax Incentives for Moderna, Vertex and More Creating 1,155 Jobs

Nineteen companies are receiving $21.4 million total in tax incentive awards to create 1,155 new life sciences jobs in Massachusetts. Moderna and Vertex received the largest awards and will add over 600 combined jobs.

October 24, 2024

·

4 min read

·

Angela Gabriel

Press Releases

Middle East Cancer Immunotherapy Market to Grow at 11.55% during 2024-2032, Impelled by Increasing Number of Clinical Trials and Research Initiatives

August 7, 2024

·

14 min read

Pictured: Photo illustration of hundred dollar bil

Series A

Myricx Bio Raises $115M in Series A to Advance ADC With Lilly and Novo Backing

The U.K.-based biotech is the latest to cash in on the hot antibody-drug conjugate space, closing a $115.5 million Series A round co-led by Novo Holdings and participation from Eli Lilly.

July 8, 2024

·

2 min read

·

Tyler Patchen

Biotech Bay

VIVUS Announces Closing of $11.55 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules

VIVUS, Inc. (Nasdaq: VVUS; the “Company”), a biopharmaceutical company, today announced the completion of its previously announced registered direct offering of 7,218,750 shares of the Company’s common stock at a purchase price of $1.60 per share for gross proceeds of $11.55 million

April 3, 2020

·

4 min read

Press Releases

Kardigan Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares

June 23, 2026

·

2 min read

Business

With 5 Gene Therapies Licensed From Penn, Passage Bio Launches With $115.5 Million Series A

Philadelphia-based Passage Bio launched with a Series A financing round worth $115.5 million. It was led by OrbiMed Advisors and joined by Frazier Healthcare Partners, Versant Ventures, New Leaf Venture Partners, Vivo Capital and Lilly Asia Ventures.

February 15, 2019

·

2 min read

·

Mark Terry

Press Releases

Kardigan Announces Pricing of Upsized Initial Public Offering

June 18, 2026

·

4 min read

Press Releases

IDEAYA Announces Closing of Public Offering Including Full Exercise of Underwriters’ Option to Purchase Additional Shares

June 11, 2026

·

3 min read

Pharm Country

Passage Bio Launches with $115.5 Million Series A to Develop AAV-Delivered Therapeutics to Treat Rare Monogenic CNS Diseases

Passage Bio today debuted with a $115.5 million Series A financing led by OrbiMed Advisors and joined by Frazier Healthcare Partners, Versant Ventures, New Leaf Venture Partners, Vivo Capital and Lilly Asia Ventures.

February 14, 2019

·

5 min read

Press Releases

Legend Biotech Corporation Announces Pricing of Public Offering - June 17, 2026

June 18, 2026

·

4 min read